These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 17122639)
1. Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma. Haghpanah V; Shooshtarizadeh P; Heshmat R; Larijani B; Tavangar SM Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):422-5. PubMed ID: 17122639 [TBL] [Abstract][Full Text] [Related]
2. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma. Ito Y; Yoshida H; Uruno T; Nakano K; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A Oncol Rep; 2003; 10(5):1337-40. PubMed ID: 12883703 [TBL] [Abstract][Full Text] [Related]
3. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma. Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712 [TBL] [Abstract][Full Text] [Related]
5. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1]. Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649 [TBL] [Abstract][Full Text] [Related]
7. Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland. Czyz W; Balcerczak E; Rudowicz M; Niewiadomska H; Pasieka Z; Kuzdak K; Mirowski M Folia Histochem Cytobiol; 2003; 41(2):91-5. PubMed ID: 12722795 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419 [TBL] [Abstract][Full Text] [Related]
9. Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors. Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J Pol J Pathol; 2004; 55(4):133-41. PubMed ID: 15757200 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of thyroid follicular neoplasms and BRAF mutation correlation. Atik E; Guray M; Gunesacar R; Ozgur T; Canda T Indian J Cancer; 2014; 51(1):63-8. PubMed ID: 24947099 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501 [TBL] [Abstract][Full Text] [Related]
12. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions. Aiad HA; Bashandy MA; Abdou AG; Zahran AA Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017 [TBL] [Abstract][Full Text] [Related]
13. Analysis of P161NK4A protein expression in follicular thyroid tumors. Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201 [TBL] [Abstract][Full Text] [Related]
14. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010 [TBL] [Abstract][Full Text] [Related]
15. Follicular lesions of the thyroid. Mathur A; Olson MT; Zeiger MA Surg Clin North Am; 2014 Jun; 94(3):499-513. PubMed ID: 24857573 [TBL] [Abstract][Full Text] [Related]
16. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy. Ippolito A; Vella V; La Rosa GL; Pellegriti G; Vigneri R; Belfiore A Thyroid; 2001 Aug; 11(8):783-7. PubMed ID: 11525273 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies. Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546 [TBL] [Abstract][Full Text] [Related]
18. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634 [TBL] [Abstract][Full Text] [Related]
19. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation. Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294 [TBL] [Abstract][Full Text] [Related]
20. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors. Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]